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Abstract 
 
 
N-(1-methylpyrene) monoaza-15-crown-5 (P5), N-(1-methylpyrene) monoaza-18-crown-
6 (P6), N-(9-anthryl-methyl) monoaza-15-crown-5 (A5), N-(9-anthryl-methyl) monoaza-
18crown-6 (A6), were synthesized and tested as fluoroionophores for potassium and 
sodium cations.  Upon metal ion complexation, fluorescence yields increased 
dramatically due to an internal photoinduced electron transfer quenching mechanism (an 
off-on fluorescence switch).   
 
The results for these model compounds led to the design and synthesis of 1,3 alternate 
calixarene[4]arenecrown-5 (I) and bicyclic peptide (V).   Calixarene I was synthesized 
and found to selectively complex potassium cations as predicted.     
 
The design of bicyclic peptide V is directed toward the selective complexation of 
ammonium cations.  The synthesis of V involved the preparation of an open chain hexa-
peptide consisting of two trityl-protected homoserine residues.  Addition of an amino 
methyl pyrene across two homoserine residues was attempted by triflating the alcohols. 
The cyclization of the peptide ring is expeded to produce a basket-like structure that 
molecular modeling indicates should have improved selectivity over that of nonactin, the 
current industry standard.   
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Introduction 
 
The focus of this research has been toward the synthesis of fluoroionophores for 
incorporation into bulk optodes for the detection of blood analyte concentrations, such as 
potassium and ammonium cations.  Blood analyte concentrations are important in 
medical diagnoses because they can indicate problems within the body. 1   The design and 
synthesis of a fluoroionophore that changes optical properties upon complexation with 
certain analytes may provide a quick and cost effective method of reliably testing blood 
analyte concentrations. 
Our research is directed toward the synthesis of various fluoroionophores that will 
ultimately lead to the fabrication of an optical sensor.   Preliminary studies included the 
synthesis and fluorescence testing of four chromophore-containing aza-crown ether 
compounds, N-(1-methylpyrene) monoaza-15-crown-5, N-(1-methylpyrene) monoaza-
18-crown-6, N-(9-anthryl-methyl) monoaza-15-crown-5, N-(9-anthryl-methyl) monoaza-
18-crown-6,  (P5, P6, A5, A6), respectively.   These studies led to the novel synthesis of 
a calixarene covalently linked to an aza crown ether, 1,3 alternate 
calixarene[4]arenecrown-5, (I),  that is N-substituted with a fluorescent anthracene group 
and is tailored for selective potassium complexation.   This research has further led to the 
design and synthesis of bicyclic peptide V, which modeling indicates should have better 
selectivity for ammonium cations than the current industry standard, nonactin.   
Biologically, the detection of ammonium cations is important because it is a 
metabolite of creatinine and urea.  Concentrations of creatinine and urea present in the 
blood can give an indication of kidney, thyroid, and muscle function.2 Since creatinine 
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and urea can both be enzymatically degraded into ammonium cation, (Scheme 1), 
bicyclic peptide V could potentially be used to test creatinine and urea concentrations.  
 
 
NH2
N
NH2+
O
OH
N NH
NH2+
O
NH4+
NH2
O
NH2
NH4+
-H2O creatininase
urease 2
urea
creatine creatinine
 
Scheme 1: Enzymatic degradation of creatinine and urea 
 
To synthesize a working fluoroionophore for the detection of cations, several 
factors were considered.  Fluoroionophores should be highly sensitive and selectively 
complex the desired cation with a high equilibrium constant for complexation.  Unwanted 
complexation with other cations can alter the optical properties of the fluoroionophore 
and in the process lower reliability of testing.  Low sensitivity to the cation desired would 
also lower the accuracy of detection.   
The selectivity of complexation of specific cations over others present is based in 
part on size-fit factors.  The fluoroionophore must possess a sufficient cavity size to 
complex specific cations.  If the cavity is too small, complexation may be impossible.  
Conversely, if it is too large, complexation may not occur.  The electrostatics of the 
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fluoroionophore also effect the complexation.  For complexation of cations to occur, 
negative charge densities must be present to interact with the positively charged cation.   
To optically detect cation concentrations, the molecule must be able to participate 
in photo-induced electron transfer (PET).  PET requires that an electron donor is able to 
travel to the fluorophore and thus quench fluorescence upon excitation.3  Cation 
complexation at the donor site consequently prevents electron transfer, thereby 
eliminating fluorophore quenching, (as shown in Figure 1). This increase in fluorescence 
is proportional to the amount of complexation and therefore the concentration of cation 
present.   
 
 
fluorophore*O
NO
OO
fluorophore*O
NO
OO
: :Na+
X
A B
 
Figure 1:  A) Model of photo-electron transfer (PET) of the amine lone pair to 
the excited fluorophore.  B) Model of sodium cation complexation of amine lone pair to 
prevent PET to the fluorophore.   
 
Due to their ability to participate in photoinduced electron transfer (PET), various 
aspects of N-substituted chromophores onto aza-crown-ether rings have been studied, 
such as pH dependence,4 cation selectivity,5,6 and spacer length effect on PET.7    The 
ability of a molecule to signal cation complexation optically is particularly attractive 
 12 
because this is a highly sensitive method of detection.3  Yoshida et. al. have noted,8 
chromophore containing aza-crown ether compounds maintain their absorption and 
emission wavelengths and absorption intensity, while their fluorescence intensities are 
significantly altered upon cation complexation.1 
 Because photo-induced electron transfer (PET) occur over a distance of 10 Å,6 
research has been done by Hai-Feng et. al. to determine the magnitude of impact on 
sensitivity due to spacer length.7   Pyrene-(CH2)n-aza-crown ether (n = 1-4) was used to 
study the effect of spacer length on PET.12  Results of these studies indicate that 
maximum efficiency is achieved when n<3 CH2 linkers,7  and methyl linked pyrene aza-
crown ether, n=1, was found to have higher selectivity for K+ than all other cations.  n=1 
methyl linked pyrenyl-aza-crown-6 showed no response to high concentrations of Na+, 
unlike the anthryl substituted counterpart.9 
  Studies done on the effects  that different chromophores have on cation 
complexation have been conducted by Kubo et. al.10 Using an aza-crown-6 with various 
chromophores attached, this work demonstrated that the size and electronic properties of 
the aromatic pendants attached to the aza-crown nitrogen may contribute to the selectivity 
of the host toward metal cations.10 
 Chromophore-containing aza-crown ether compounds are an attractive model, as 
they complex cations that in turn effectively inhibit PET, thereby making them excellent 
cation concentration sensors.  However, chromophore-containing aza-crown ether 
compounds do not selectively complex certain cations,9 making them of little use in 
blood analyte testing.  They also suffer pH dependence problems, where protonation of 
the amine mimics cation complexation at low pH.  In some studies, 
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benzyltrimethylammonium hydroxide, (BTMAH), is employed to insure deprotonation of 
the amine.7,8   To avoid this problem benzo-crown ethers have been used.  In these 
systems, the alkoxy-substituted benzene ring is able to participate in PET rather than the 
amine.  However, in some cases, using a benzo-crown ether lowers the overall 
fluorescence enhancement, FE, obtained, FE=15 vs. 47.3 
 To help increase crown selectivity, the use of crown ethers covalently-bound to 
calix[4]arenes have been studied extensively.11,12,13,14,15,16,17,18,19,20,21,22,23,24 Reinhoudt at 
al. reported selective binding of potassium ions (relative to sodium or lithium) to 
calix[4]crown-5 structures, noting that the K+/Na+ selectivity was dependent on the 
calix[4]crown conformation (i.e., cone, partial cone or 1,3-alternate). 9,12  
Since these early reports, studies have expanded to include benzocrown and 
azacrown structures and their selectivity and sensitivity for binding a wide variety of 
metal cations and their practical application as sensors. Dabestani et al. reported the 
synthesis and characterization of an o-benzocrown-6-calix[4]arene structure consisting of 
a 9-cyanoanthracenyl chromophore covalently-linked through a methylenic bridge to the 
benzo group.13,15,16  This  fluoroionophore acts as an on-off fluorescence switch that is 
triggered by ion complexation. In the absence of cation, the benzocrown group quenches 
the cyanoanthracenyl excited singlet state by electron transfer, while in the presence of 
complexed cation, the electrostatic field of the ion disrupts the electron transfer process.  
This particular system exhibited high sensitivity for Cs+ ion, important in the detection of 
radioactive contamination, and relatively good selectivity for Cs+ over other alkali metal 
ions.  Similar structures make use of azacrown rings instead of 
benzocrowns,17,18,19,20,21,22,23 presumably because the lower oxidation potential of the 
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amine relative to the benzo group allows greater flexibility in the selection of the 
fluorophore used in the system, i.e., the amine provides greater driving force for the 
electron transfer process. Kim et al.22 have synthesized azacrown-5 calix[4]arenes where 
the nitrogen of the azacrown is substituted with benzyl or picolyl groups. In the picolyl 
systems, selectivity for Ag+ ions was found to be an order of magnitude higher than for 
other cations measured.  The presence of the pyridinyl ring apparently contributes to the 
metal ion binding.   
Based on the above, we have synthesized I, which combines the known optical 
response of anthryl azacrown-6 to K+, with the expected enhanced selectivity provided by 
coupling the azacrown to a 1,3-alternate calix[4]arene.  Fluorescence testing indicates 
increased selectivity for K+ over Na+ and a high sensitivity for K+ in the human 
physiological range. 
Considered to be the three-dimensional equivalent of crown ethers, cryptands 
incorporate N as well as O atoms and show stronger complexation behavior than the 
crowns.25  Spherical macrotricycles, also known as supercryptands, have four identical 
faces each being composed of an 18-membered ring connected at the nitrogen sites.26   
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Figure 2: A) Structure of cryptand [2.2.2]    B) Structure of supercryptand 
 
The macrobicyclic ligand, cryptand [2.2.2], is known to complex with ammonium 
ions, but the spherical macrotricycle, supercryptand, forms an even stronger complex.27  
Macrobicyclic ligand  [2.2.2] is known to selectively bind K+ while the spherical 
macrotricyclic ligand selectively binds NH4+.27,28,29  The NH4+ < K+ binding selectivity of 
cryptand [2,2,2] may be related to its O/N ratio and smaller cavity size.  The K+ < NH4+ 
preference of the supercryptand results from a larger number of N sites, a larger cavity 
size and a tetrahedral arrangement of the four N sites.27,  
Traditionally, nonactin, shown in Figure 3, a natural antibiotic agent, utilizes four 
ethereal and four carbonyl oxygen atoms to bind NH4+. 30   Because binding of 
ammonium cation to nonactin is coupled with a proton transport, the dynamic range can 
be varied by the adjustment of the pH of the ammonium solution.  At pH 7, 
measurements can be achieved in the range from 0.1 to 10 mM ammonium ion.31 
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Figure 3: Structure of Nonactin 
 
A novel ammonium ionophore that exhibits better selectivity than the natural 
antibiotic nonactin was successfully designed and synthesized based on a 19-membered 
crown compound having the decalino subunits in the macrocyclic system shown in 
Figure 4.32 The use of bulky decalino groups has been employed to provide structure 
rigidity, and block the complexation of larger ions, while also increasing the lipophilicity 
of the ionophore molecule.  The structural rigidity is thought to decrease the likelihood of 
complexing smaller ions such as Li+, Na+, and even K+, while the bulkiness of the groups 
prevents the complexation of larger ions such as Rb+ and Cs.+  The 19-membered crown 
was found to exhibit 10 times the selectivity over K+ and 3000 times the selectivity over 
Na,+  thereby making it more selective than nonactin. 
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Figure 4:  19-crown-6 ether with decalino subunits 
 
Several cyclic peptide systems have also been synthesized for ammonium 
complexation.  Kunik et. al constructed a cyclic peptide composed of L-proline and  three 
amino benzoic acids in an alternating sequence that was able to bind ammonium with 
stability constants between 11000 and 42000 M-1 in chloroform.33  Bicyclic peptide 
systems have also been synthesized.  Zanotti et al. reported models of bicyclic peptides 
cyclo-(Glu1-Leu2-Pro3-Gly4-Ser5-Ile6-Pro7-Ala8)-cyclo(1-5ß) Phe9-Gly10, as well as (Glu1-
X2-Pro3-Gly4-Lys5-X6-Pro7-Gly8)-cyclo(1γ-5ε) where X was Ala or Leu, respectively,34 
shown in Figure 5.  The most significant deviation found in the ion-binding properties of 
X=Ala and X=Leu was the fact that stable Na+, K+, and Ba2+ complexes were formed 
with X=Leu and not with X=Ala on the NMR time scale.35 Another eight-membered 
bicyclic peptide, cyclo-(1,5-ε-succinoyl)(Lys-Gly-Gly-Gly)2, has been synthesized by 
Crusi, et al. demonstrating high selectivity for Sr2+ cation.36 
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Figure 5: Bicyclic peptide structures 
1) cyclo-(Glu1-Leu2-Pro3-Gly4-Ser5-Ile6-Pro7-Ala8)-cyclo(1-5ß) Phe9-Gly10 
 2) cyclo-(Glu1-X2-Pro3-Gly4-Lys5-X6-Pro7-Gly8)-cyclo(1γ-5ε) X = Ala or Leu 
3) cyclo-(1,5-ε-succinoyl)(Lys-Gly-Gly-Gly)2 
 
Based on these previous studies and on work from our laboratory on ammonium 
ion complexation37, we have designed and undertaken the synthesis of (V), a bicyclic 
peptide that is constructed of a main ring of the sequence cyclo-[L-Ala-D-Hse-L-MeAla-
D-Ala-L-Hse-D-Ala], with a pyrenyl-methyl-amine bridge across the two homoserine 
alcohols.   Modeling has shown that bicyclic peptide V should exhibit high selectivity for 
ammonium cations.  
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Experimental 
 
I. General Materials 
 
 
All reagents were used as received without further purification.   1-aza-15-crown-5 
(97%), 1-aza18-crown-6 (95%), 9-chloroanthracene (96%), 1-pyrenemethanol (98%), 
phosphorus tribromide, benzyltrimethylammoniumhydroxide, potassium acetate, sodium 
acetate, triethylamine, piperidine, acetonitrile (anhydrous), trifluoromethanesulfonic 
anhydride, trifluoromethanesulfonic chloride, 1-pyrenemethylamine hydrochloride, 
ethanol, methanol, and ethyl acetate were all purchased from Aldrich Chemicals.  2-
Chlorotrityl Chloride resin (1.0mmol/g loading) 200-400 mesh, 1%DVB, Fmoc-Ala-OH, 
Fmoc-D-Hse(Trt)-OH, Fmoc-MeAla-OH, Fmoc-D-Ala-OH, 1-hydroxybenzotriazole 
hydrate (HOBT), and PyBop were purchased from Nova Biochem.  Fmoc-Hse(trt)-OH, 
tBoc-Ala-OH, and trifluoro-acetic acid were purchased from Advanced Chemtech.  The 
Diisopropylethylamine was purchased from Avocado Research Chemicals Ltd; 
triisopropylsilane 99% from Acros; dimethylformamide from J.T. Baker; 
dichloromethane and hexane from VWR.  Anhydrous magnesium sulfate was purchased 
from Mallinchrodt. 
 
II. General Methods 
 
i. NMR 
 
Proton nuclear magnetic resonance (1H NMR) spectra were obtained on a Bruker 
AVANCE 400 (400 MHz) NMR spectrometer. Chemical shifts are reported in ppm (δ). 
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Carbon nuclear magnetic resonance (13C NMR) spectra were recorded at 100 MHz on the 
same instrument mentioned above. 
 
ii. UV-Visible Spectroscopy 
 
Ground state absorption spectra were measured in a quartz cuvette (1cm x 1cm) with a 
Shimadzu UV 2100 Spectrophotometer. Samples were measured in single beam mode 
and compared with a blank obtained with pure solvent. Extinction coefficients were 
calculated via Beer’s law. 
 
iii. Infrared Spectroscopy 
 
Infrared spectra were obtained on a Perkin-Elmer Spectrum One FT-IR spectrometer 
supported in KBr (Aldrich, Standard IR Grade).  Samples were prepared with an IR press 
of 13mm diameter (Z11,241-0) under 10 tons of pressure using a vacuum pump for 10 
minutes. 
 
iv. Fluorescence Spectroscopy 
 
Fluorescence spectra were obtained at room temperature in a quartz cuvette 
(1 cm x 1 cm) in air saturated solvent using a Perkin-Elmer LS-50B Spectrofluorimeter.  
 
v. Mass Spectrometry 
 
Mass Spectra were performed by SYNPEP Corporation, Dublin, CA. The carrier solvent 
used was a mixture of H2O and acetonitrile (1:1).  The sample was ionized by 
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electrospray and injected using compressed air.  The mass spectrometer used ultra-grade5 
nitrogen as a curtain gas. 
 
vi. Thin Layer Chromatography (TLC) 
 
Analytical TLC was performed using pre-coated silica gel plates (Whatman 200 µm 
KCF18 silica gel 60A reverse phase plates or Whatman 250 µm thickness KF6F silica gel 
60A normal phase plates), which were illuminated by a UV lamp at 254 nm and 356 nm.   
 
vii. Flash Chromatography 
 
Flash chromatography was performed on a Biotage Flash 12i using KP-Sil  32-63 µm 
60A silica gel under N2 pressure.   
 
viii. Preparative Thin Layer Chromatography 
 
Preparative TLC was performed using precoated silica gel plates (1000 µm Whatman 
K6F silica gel 60A). 
 
 
ix. Melting Point Apparatus 
 
All melting points were obtained using a Fisher-Johns Melting point apparatus and are 
uncorrected.  
 
x. Computational studies 
 
Molecular structures were minimized using a SGI 320 running Windows NT.  All calculations 
were performed using the Molecular Operating Environment (MOE), version 2000.02 computing 
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package (Chemical Computing Group Inc., Montreal, Quebec, Canada.).  Dynamics calculations 
on structures were heated to 400 K, equilibrated at 310 K and cooled to 290 K at a rate of 10 
K/ps.  The lowest energy structures obtained from these calculations were re-minimized.  
Electrostatic calculations were performed on these structures using default parameters. 
 
 
 
III. Synthesis 
 Synthetic details are provided below.  All data cited can be found in Appendix A. 
 
 
 
OH Br
0.3 eq. PBr3
benzene
 
Scheme 2: Formation of 1-(Bromomethyl)pyrene 
 
i.  1-(Bromomethyl)pyrene 
 
1-Pyrene methanol (4.500g, 1.94mmol) and PBr3 (2.1g, 0.74mL) were refluxed in 
benzene (250mL) for 4 hrs. The reaction was followed with normal phase TLC with 
DCM as the mobile phase. The solution was extracted with a 3:2 diethyl ether: water 
(60mL: 40mL) mixture, rinsed with water twice, and dried over anhydrous sodium 
sulfate.  The solvent was then removed under reduced pressure to yield 1-(bromomethyl) 
pyrene as a yellow solid (95.4% yield) (5.450g, 1.84mmol).  1H NMR (CDCl3). δ 5.28 (s, 
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2H), 8.0-8.3 (m, 9H) 13C NMR (CDCl3). δ 32.205 (CH2), 122.818-131.963 (pyrene). 
[Scheme 2] 
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Scheme 3: Formation of N-(1-methylpyrene) monoaza-15-crown-5 (P5) 
 
ii. N-(1-methylpyrene) monoaza-15-crown-5 (P5) 
 
1-aza-18-crown-6 (0.464g, 2.1mmol), 1- (bromomethyl) pyrene (0.520g, 1.76mmol), and 
triethylamine (0.526g, 0.74mL) were refluxed in 1,4-dioxane (200mL) for 48 hrs.  The 
solvent was evaporated, and the product extracted with DCM:H2O (2:3). The organic 
phase was rinsed three times with water and then dried over anhydrous magnesium 
sulfate.  The crude product was purified using prep-TLC plates in the absence of ambient 
light. (DCM:EtOH 17:1 as eluent), to yield N-(1-methylpyrene) monoaza-15-crown-5 
(0.412 g, 0.95mmol) as an oil (45.25% yield overall). Rf 0.13 DCM: EtoAc (17:1). 1H 
NMR (CDCl3). δ 8.1-7.9 (m, 9H), 4.3 (s, 2H), 3.7-3.5 (m, 20H), 2.9 (t, 4H).  13C NMR 
(CDCl3). δ 54.9 (CH2), 59.5 (CH2), 71.4-70.4 (CH2 crown), 133.6-123.8 (pyrene). MS 
m/z (M+) calcd. 434.54 found 434.2. [Scheme 3] 
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Scheme 4: Formation of N-(1-methylpyrene) monoaza-18-crown-6 (P6) 
 
iii. N-(1-methylpyrene) monoaza-18-crown-5 (P5) 
 
1-aza-18-crown-6 (0.553g, 2.10mmol), 1- (Bromomethyl) Pyrene (0.520g, 1.76mmol), 
and triethylamine (0.526g, 0.74mL) were refluxed in 1,4-dioxane (200mL) for 24 hrs.  
The solvent was evaporated, and the product extracted with DCM:H2O (2:3). The organic 
phase was rinsed three times with water and then dried over anhydrous magnesium 
sulfate.  Further purification was done using preparative TLC in the absence of ambient 
light.  (DCM:EtOH 17:1 as eluent), to yield N-(1-methylpyrene) monoaza-18-crown-6. 
(0.0601g, 0.138mmol) as an oil (6.8% yield overall). Rf 0.03 DCM: EtoAc (17:1). 1H 
NMR (CDCl3). δ 8.5-7.9 (m, 9H), 4.3 (s, 2H), 3.6-3.4 (m, 20H), 2.9 (t, 4H).  13C NMR 
(CDCl3). δ 54.9 (CH2), 58.77 (CH2), 71.1-70.2 (CH2 crown), 133.6-123.8 (pyrene). MS 
m/z (M+) calcd. with Na+ 500.59 found 500.2. [Scheme 4] 
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Scheme 5: Formation of N-(9-anthryl-methyl) monoaza-15-crown-5 (A5) 
 
 
iv. N-(9-anthryl-methyl) monoaza-15-crown-5 (A5)  
 
1-aza-15-crown-5 (0.464g, 2.10mmol), 9-chloromethylanthracene (0.400g, 1.76mmol), 
and triethylamine (0.526g, 0.74mL) were refluxed in 1,4-dioxane (200mL) for 48 hrs.  
The solvent was evaporated, and the product extracted with DCM:H2O (2:3). The organic 
phase was rinsed three times with water and then dried over anhydrous magnesium 
sulfate.  Further purification was done using preparative TLC in the absence of ambient 
light.  (DCM:EtOH 17:1 as eluent), to yield N-(9-Anthryl-methyl) monoaza-15-crown-5 
(0.440g, 1.07mmol) as yellow oil (60.8% yield overall). Rf 0.03 DCM: EtoAc (17:1). 1H 
NMR (CDCl3). δ 9.0-7.5 (m, 9H), 4.6 (s, 2H), 3.7-3.5 (m, 20H), 2.9 (t, 4H).  13C NMR 
(CDCl3). δ 52.9 (CH2), 54.5 (CH2), 71.4-70.4 (CH2 crown), 131.8-125.2 (anthryl). 
[Scheme 5] 
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Scheme 6: Formation of N-(9-anthryl-methyl) monoaza-18-crown-6 (A6) 
 
v. N-(9-anthryl-methyl) monoaza-18-crown-6 (A6) 
 
1-aza-18-crown-6 (0.515g, 1.95mmol), 9-chloromethylanthracene (0.400g, 1.76mmol), 
and triethylamine (0.526g, 0.74mL) were refluxed in 1,4-dioxane (200mL) for 24 hrs.  
The solvent was evaporated, and the product extracted with DCM:H2O (2:3). The organic 
phase was rinsed three times with water and dried over anhydrous magnesium sulfate.  
Further purification was done using preparative TLC in the absence of ambient light.  
(DCM:EtOH 17:1 as eluent), to yield N-(9-anthryl-methyl) monoaza-18-crown-6 
(0.176g, 0.388mmol). The product was then recrystalized with dichloromethane and ether 
to yield a yellow solid (22% yield overall). mp.80º-82ºC, Rf 0.05 DCM: EtoAc (17:1).  
1H NMR (CDCl3). δ 8.6-7.4 (m, 9H), 4.6 (s, 2H), 3.7-3.5 (m, 20H), 2.9 (t, 4H).  13C NMR 
(CDCl3). δ 52.4 (CH2), 54.3 (CH2), 71.3-70.6 (CH2 crown), 131.8-124.8 (anthryl). MS 
m/z (M+) calcd. 454.54 found 454.2. [Scheme 6] 
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vi. Synthesis of 1,3 alternate calixarene[4]arenecrown-5 (I) 
 
 The synthesis of 1,3 alternate calixarene[4]arenecrown-5 was done by Dr. Hubert 
Nienaber and the experimental detail can be found in reference 13.38 
 
 
vii. Synthesis of bicyclic peptide (V) 
 
 The synthetic pathway used toward the construction of bicyclic peptide V is 
shown below.  An Fmoc solid phase synthesis using a 2-Chlorotrityl Chloride resin was 
employed along with an N-terminus tBoc protecting group and trityl protected 
homoserine residues.  Upon cleavage, the trityl groups, located on the homoserine side 
chains, were removed and cyclization of the side chains attempted.  
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Scheme 7: Loading of 2-Chlorotrityl chloride resin 
 
vi. Loading Resin 
 
2-Chlorotrityl Chloride resin (1.0mmol/g, 4.600g) was swelled in a peptide synthesizer 
(100mL) for 3 minutes by bubbling N2 through dry DCM.   1.2 eq. of Fmoc-Ala-OH 
(1.718g, 5.52mmol) and 4.0 eq. of DIPEA (3.21mL, 18.40mmol) were dissolved in dry 
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DCM (60mL) and added to the resin.  After 2 hours, the mixture was drained and rinsed 
2x with 25mL of DCM:MeOH:DIPEA (17:2:1), 3x DCM, 3x DMF, 2x DCM. [Scheme 
7] 
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Scheme 8: Deprotection of Fmoc-Ala-Resin 
 
vii. Deprotection of Fmoc-Ala-Resin 
 
The Fmoc-Ala-Resin was deprotected with 20% piperidine in DCM for 20 minutes.  The 
resin was shrunk and reswelled to remove all reagents by rinsing 2x with 40mL DCM, 3x 
MeOH, 2x EtOH, 3x DCM.  A negative Kaiser test was obtained, indicating free amine 
was present.  The Kaiser test was prepared by mixing 2 drops of each solution with the 
resin and then heating in the oven for 3-5 minutes.  The solutions were prepared as 
indicated in Nova Biochem by: dissolving 5g of ninhydrin in 100mL ethanol; dissolving 
80g of liquefied phenol in 20mL ethanol; adding 2mL of a0.001M aqueous solution of 
potassium cyanide to 98mL pyridine.  A positive test indicates free amine by the presence 
of blue beads.  [Scheme 8] 
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Scheme 9: Coupling of Fmoc-D-Hse-OH 
 
viii. Coupling Fmoc-D-Hse-OH 
1.25 eq. of Fmoc-D-Hse-OH (3.356g, 5.75mmol), 1.25 eq. HOBT (0.777g, 5.75mmol), 
1.35 eq. PyBop (3.231g, 6.21mmol), and 2.5 eq. DIPEA (2.00mL, 11.50mmol) were 
dissolved in 40mL of DMF and added to the resin-Ala-NH2. DCM (40mL) was then 
added to the peptide synthesizer to facilitate solvation and the reaction was carried out 
over night.  The mixture was then drained and rinsed 2x with 40mL DCM, 3x MeOH, 2x 
EtOH, and 3x DCM.   A positive Kaiser test was obtained, indicating the absence of 
amine. [Scheme 9] 
 
ix. Coupling Fmoc-MeAla-OH 
 
The Fmoc-D-Hse-Ala-resin was deprotected via the procedure above. 1.5 eq. of Fmoc-
MeAla-OH (2.245g, 6.90mmol), 1.5 eq. HOBT (0.932g, 6.90mmol), 1.6 eq. PyBop 
(3.829g, 7.36mmol), and 2.5 eq. DIPEA (2.40mL, 13.80mmol) were dissolved in 40mL 
of DMF and added to the resin-Ala-D-Hse-NH2. DCM (40mL) was then added to the 
peptide synthesizer to facilitate solvation and the reaction continued for 5 hours.  A 
seemingly positive Kaiser test was obtained 2x, so the mixture was then drained and 
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rinsed 2x with 40mL DCM, 3x MeOH, 2x EtOH, and 3x DCM and the coupling repeated 
with 0.3 eq of Fmoc-MeAla-OH (0.440g, 1.35mmol), 0.3 eq. HOBT (0.182g, 1.35mmol), 
1.6 eq. PyBop (0.702g, 1.51mmol), and 0.6 eq. DIPEA (0.47mL, 2.70mmol) were 
dissolved in 40mL DCM and DMF for 4 hours.  A positive Kaiser test was obtained. 
 
x. Coupling Fmoc-D-Ala-OH 
 
The Fmoc-MeAla-D-Hse-Ala-resin was deprotected via the procedure above. 1.5 eq. of 
Fmoc-Ala-OH (2.148g, 6.90mmol), 1.5 eq. HOBT (0.932g, 6.90mmol), 1.6 eq. PyBop 
(3.829g, 7.36mmol), and 2.5 eq. DIPEA (2.40mL, 13.80mmol) were dissolved in 40mL 
of DMF and added to the resin-Ala-D-Hse-MeAla-NH2. DCM (40mL) was then added to 
the peptide synthesizer to facilitate solvation and the reaction carried out for 6 hours.  The 
mixture was then drained and rinsed 2x with 40mL DCM, 2x MeOH, 1x EtOH, 2x DCM.  
No reliable secondary amine test was found, so the coupling was repeated with 0.8 eq. of 
Fmoc-Ala-OH (1.145g, 3.68mmol), 0.8 eq. HOBT (0.497g, 3.68mmol), 0.9 eq. PyBop 
(2.154g , 4.12mmol), and 1.6 eq. DIPEA (1.28mL, 7.36mmol) to insure complete 
coupling.  The mixture was then drained and rinsed 2x with 40mL DCM, 3x MeOH, 2x 
EtOH, 3x DCM.   
 
xi. Coupling Fmoc-Hse-OH 
 
The Fmoc-D-Ala-MeAla-D-Hse-Ala-resin was deprotected via the procedure above. 1.25 
eq. of Fmoc-Hse-OH (3.356g, 5.75mmol), 1.25 eq. HOBT (0.777g, 5.75mmol), 1.35 eq. 
PyBop (3.231g, 6.21mmol), and 2.5 eq. DIPEA (2.00mL, 11.50mmol) were dissolved in 
40mL of DMF and added to the resin-Ala-D-Hse-MeAla-D-Ala-NH2. DCM (40mL) was 
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then added to the peptide synthesizer to facilitate solvation and the reaction was 
continued for 4 hours.  The mixture was then drained and rinsed 2x with 40mL DCM, 3x 
MeOH, 2x EtOH, and 3x DCM.  A positive Kaiser test was obtained, indicating the 
absence of amine. 
 
xii. Coupling tBoc-Ala-OH 
 
The Fmoc-Hse-D-Ala-MeAla-D-Hse-Ala-resin was deprotected via the procedure above. 
1.50eq. tBoc-Ala-OH (1.305g, 6.90mmol), 1.5 eq. HOBT (0.932g, 6.90mmol), 1.6 eq. 
PyBop (3.829g, 7.36mmol), and 2.5 eq. DIPEA (2.40mL, 13.80mmol) were dissolved in 
40mL of DMF and added to the resin-Ala-D-Hse-MeAla-NH2. DCM (40mL) was then 
added to the peptide synthesizer to facilitate solvation and the reaction carried out for 3 
1/2 hours.  The mixture was then drained and rinsed 2x with 40mL DCM, 3x MeOH, 2x 
EtOH, and 2x MeOH.  A positive Kaiser test was obtained, indicating the absence of 
amine. 
OH
N
H
N
H
N
N
H
N
H
N
H
O
CH3 O
O O
O
O
CH3
CH3
CH3
O
CH3
O
O
O
CH3
CH3
CH3
trt
trt
Cl
O Peptide
Ala-D-Hse-MeAla-D-Ala-Hse-D-Ala-tBoc
1% TFA
R
 
Scheme 10: Cleavage of peptide from resin 
 
xiii. Peptide Cleavage 
 
The shrunken resin was dried using N2 and cleaved in fractions with 1%TFA in DCM 
(250mL total) in the peptide synthesizer.  The cleavage solution (~42mL) was bubbled 
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with N2 for 5 minutes, drained into 10% pyridine in methanol (4.3mL), and collected 
separately in six 50mL Erlenmeyer flasks.  Equivalent molar amounts of TFA and 
pyridine were used to minimize the amount of excess acid and base.  The peptide was 
then bubbled and rinsed with DCM and MeOH  and collected separately.  Fractions 1-8 
were spotted on a normal phase TLC plate using EtoAc:MeOH (3:1) as an eluent.  
Fractions 1 and 2 were placed in a 250mL round bottom flask and evaporated to ~5%.  
Distilled water was added, and the solution was adjusted to a pH of ~7 using pyridine to 
precipitate the peptide as a white solid (2.100g, 1.90mmol).  Fractions 3-8 were 
combined in a 500mL round bottom flask and evaporated to ~5%.  Distilled H2O was 
added and the solution determined to have a pH of ~1; pyridine was added to adjust the 
pH to ~7 to precipitate the peptide (0.400g, 0.36mmol).  mp.72º-74ºC, Rf 0.43 
DCM:MeOH (10:1) (with 2 drops base-piperidine).  1H NMR (CDCl3). δ 9.5-9.4 (m, 
COOH), 8.6 (s, 6NH), 7.9-7.2 (m, 30H trityl), 4.0-4.6 (m, 6CH), 3.1-2.9 (m, 1CH3N), 
2.3-1.8 (t, 2CH2OH), 1.4-1.2 (t, 7CH3+2CH2).   13C NMR (CDCl3). δ 13.6 (CH3), 28.2 
(tboc-CH3), 48.3 (NCH3), 53.4 (CH2), 59.3 (CH2), 86.9-86.4 (CH), 128.6-126.7 (CH 
trityl), 147.0-143.8 (3C), 155.7 (CONH), 171.5 (COOH) 175.0-173.3 (CO). 135C NMR 
(CDCl3). δ 14.6 (CH3), 29.3 (tboc-CH3), 53.0 (NCH3), 54.5 (CH2), 60.0 (CH2), 129.7-
128.0 (CH trityl), 130.9 (CONH), 146.4-141.6 (COOH).  MS m/z (M+) with Na+ calcd. 
1126.29  found 1126.462.  [Scheme 10] 
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Scheme 11: Deprotection of alcohols 
 
xiv. Deprotection of Alcohols 
 
The protected linear peptide (2.020g, 1.83mmol) was dissolved in 50mL of 
DCM:TIS:TFA (48:1.5:0.5) for 10 minutes forming a light yellow solution.  All solvents 
were evaporated to yield a slightly crystalline light yellow oil.  The trityl groups were 
precipitated using MeOH.  The final amount of trityl groups removed by column 
chromatography using Hexane:EtoAc (1:1) as eluent and the peptide rinsed through using 
MeOH to obtain a white solid (1.121g, 1.82mmol) in a 99.4% yield.  mp.54º-56ºC, Rf 
0.14 EtoAc:DCM:MeOH (2:1:1).  1H NMR (MeOD). δ 7.4-7.3 (m, 6NH), 3.08-3.07 (s, 
2CH2OH), 2.9-2.8 (m, 1CH3N), 2.5-2.9 (t, 2CH2), 1.3-1.0 (t, 7CH3).   13C NMR 
(MEOD). δ 14.6 (CH3), 28.2 (tboc-CH3), 52.4 (CH2), 35.7 (CH2), 81.1 (CH), 158.3 
(CONH), 163.3 (COOH) 176.9-172.7 (CO). 135C NMR (MeOD). δ 14.6 (CH3), 29.2 
(tboc-CH3), 53.1 (NCH3), 35.5 (CH2), 58.0 (CH2), 130.9 (CONH).  MS m/z (M+) with 
Na+ calcd. 641.66  found 641.32. [Scheme 11] 
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Scheme 12: Triflation and pyrene addition  
 
 
xv. Triflation and pyrene addition 
 
Linear peptide (0.238g, 0.38mmol) and Et3N (0.18mL, 1.29mmol) were dissolved in 
150mL of acetonitrile and cooled to 0º C.  Triflic chloride (.10mL, 0.915mmol) was 
added dropwise while stirring and then allowed to warm to room temperature for 1 hour.  
The orange solution was evaporated to yield a yellow oil.   
1-Pyrenemethylamine hydrochloride was washed with DCM and 2N NaOH to 
extract 1-pyrenemethylamine into the organic layer.  The organic layer was then dried, 
and 1-pyrenemethylamine (0.088g, 0.34mmol) was dissolved in acetonitrile with Et3N 
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(0.21mL, 1.52mmol).  This mixture was then added dropwise to the triflated peptide to a 
volume of 350mL.  A low concentration was used (0.95mg/mL) to ensure that the 
reaction would be intermolecular rather than intramolecular.   The solution turned from 
cloudy orange to clear light orange overnight.  1H NMR (MeOD). δ 8.2-7.9 (m, 9H 
pyrene), 7.3 (s, 6NH), 3.8-4.4 (m, 6CH), 3.7 (m, CH2pyrene), 2.9 (m, 1CH3N), 2.5 (t, 
2CH2N), 2.0 (t, 2CH2), 1.3-1.1 (t, 21CH3). [Scheme 12] 
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Results and Discussion 
 Details of the synthesis and fluorescence testing of the four aza crown ethers, 1,3 
alternate calixarene[4]arenecrown-5, and bicyclic peptide V are discussed below.  
 
I. Aza-crown-ethers 
i. Synthesis 
Chromophore containing aza-crown ether compounds were studied as models for 
both 1,3 alternate calixarene[4]arenecrown-5 and bicyclic peptide V.  All four 
chromophore containing aza-crown ether compounds were synthesized by the same 
synthetic pathway.    Following a literature procedure,39  1.0 equivalent of the 
chromophore, 1.2 equivalents of the aza-crown ether, and 2.5 equivalents of 
triethylamine were dissolved in 1,4 dioxane.  The reaction proceeds via an SN2 
mechanism, (see Scheme 13 below).  After 48 hours, the solvent was evaporated and the 
product extracted into DCM and washed with water.  The organic layer was dried over 
MgSO4, rather than NaSO4, to prevent any possible contamination or complexation 
between the sodium cations and the aza-crown ether moiety.   
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Scheme 13: Mechanism of pyrene addition to aza crown ether 
 
Further purification was achieved using preparative thin layer chromatography 
plates with DCM:EtOH (17:1) as eluent.  All plates were run in the dark and the silica 
removed before the solvent was fully allowed to dry.  Initial chromatography done under 
ambient light conditions caused an apparent decomposition of the product.  A literature 
search concluded that pyrene is known to photo-oxidize on unactivated and activated 
silica.40,41,42  Mechanistic studies done by Reyes et. al. concluded that the pyrene cation 
radical forms by an electron transfer from the pyrene excited state to oxygen or by photo-
ionization of pyrene and is the precursor to the photoproduct formation.  The pyrene 
cation radical then reacts with physisorbed water on silica to give 1,8-pyrenedione, 1-
hydroxypyrene, 1,6-pyrenedione, along with minor products.41   
Higher product yields were obtained when using 1-aza-15-crown-5 (P5 42.5%, 
A5 60.8%).  The reason for this result is unclear at this time, but may be due to the fact 
that the amine 1-aza-15-crown-5 may be more rigid and less sterically hindered than the 
1-aza-18-crown-6 (P6 6.8%, A6 22.0%), enabling it to be more reactive.  Adding the 
anthracene moiety to the aza-crown ethers also proceeded in overall higher yields than 
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the addition of the 9-methylpyrene and is likely due to the higher reactivity of the 9-
chloromethylanthracene moiety. 
Characterization of each chromophore-containing aza-crown ether was done 
primarily with NMR and Mass Spectroscopy.  All spectral data can be found in Appendix 
A. 
 
ii. Photo-electron transfer (PET) 
Chromophore-containing aza-crown ethers are able to participate in photoinduced 
electron transfer (PET), where, upon excitation an electron of the lone pair on the 
nitrogen is able to travel to the chromophore, quenching the fluorescence.7   Upon 
complexation with a cation, the electrostatic field of the amine is disrupted, thereby 
preventing PET and causing an increase in fluorescence intensity proportional to the 
concentration of cations.  
The thermodynamics of PET are described by the simplified Rehm-Weller 
equation (1). ∆GPET is calculated to determine the spontaneity of the PET process for 
chemosensors with a fluorophore-spacer-receptor system. 
 
          ∆GPET = Eox – Ered – e2/εr – Eoo           (1) 
  
Here, ∆GPET is the free energy for the PET process, Eox is the oxidation potential of the 
amine, Ered is the reduction potential of the chromophore, and ε the dielectric constant of 
the solvent.   The oxidation potential of the aza-crown ether moiety is reported to be 
+0.84 V vs. Ag/AgCl.1   Values for the reduction potential of the anthracene and pyrene 
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were converted from SCE to Ag/AgCl and found to be -1.93 eV and –2.10 eV, 
respectively.43  A value of e2/εr was approximated to be -0.1 eV1 and the singlet-singlet 
energy was calculated to be 3.28ev for anthracene and 3.34 eV for pyrene. 43  Using the 
Rehm-Weller equation, ∆GPET of the anthryl-aza-crown-ethers was calculated to be  –
0.41 eV and the ∆GPET of the pyrenyl-aza-crown-ethers –0.30 eV.  The negative values 
for PET in these systems indicate that electron transfer quenching is a spontaneous 
process.  The thermodynamic requirement for spontaneity is crucial in the design of 
cation-sensing systems and is always the first consideration.   
  
iii. Fluorescence Data 
 
Fluorescence spectra were obtained in air saturated 1:1 DCM: MeOH at 
concentrations between 2.0x10-4 M and 2.2 x10-4 M by preparing a stock solution of 
0.010g, in 100mL of a 1:1 solution.  A6 was also tested in DCM, providing a comparison 
with 1,3 alternate calixarene[4]arenecrown-5 and determination of solvent effects. The 
stock solution was then used (0.5mL) to prepare (10mL) a 1.0x10-5 M – 1.2 x10-5 M 
solution.  All fluorescence emission spectra were obtained with the slit widths set at 5.0 
nm for the excitation monochromator and 2.5 nm for the emission monochromator on a 
Perkin-Elmer LS-50B.  The samples were prepared as follows with each UV absorbance 
at the excitation wavelength noted.   
Sodium acetate salt (0.01M stock solution) in 1:1 DCM MeOH was used as the 
sodium cation in experiments with both aza-crown-5 compounds.  Potassium acetate salt 
(0.005M stock solution) in 1:1 DCM: MeOH was used as the potassium cation in 
experiments with both aza-crown-6 compounds. Benzyltrimethylammonium hydroxide 
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(0.0055M stock solution) in 1:1 DCM: MeOH was used as a proton scavenger in each of 
the samples. Data is shown in Table 1. 
 
 
Sample Concentration Excitation Abs.  
  [M] nm   
N-(1-methylpyrene) monoaza-15-crown-5 (P5)    1.15 x10-5 333 0.153 
  N-(1-methylpyrene) monoaza-18-crown-6 (P6) 1.00 x10-5 333 0.165 
  N-(9-anthryl-methyl) monoaza-15-crown-5 (A5) 1.22 x10-5 355 0.048 
  N -(9-anthryl-methyl) monoaza-18-crown-6 (A6) 1.10 x10-5 355 0.040 
 
Table 1: Sample Concentrations of P5, P6, A5, A6, in 1:1 DCM:MeOH, A6 in DCM, 
and each absorbance at the given wavelength of excitation 
 
 
 
Fluorescence spectra obtained upon the addition of each cation concentration are 
shown below along with a plot of the fluorescence area compared to cation concentration. 
[Figures 6-13]  From these plots it can be seen that the complexation of cation is linearly 
proportional to the fluorescence area obtained.  Once all possible complexation has taken 
place, the plot begins to plateau and the fluorescence area and intensity reach a maximum 
regardless of the amount of cation added.  For A6 and P6, this plateau is observed at a 
marginally higher concentration of cation than the host molecule, likely due to the value 
of the complexation constant.  A significantly higher concentration of cation is needed for 
A5 and P5 in order to reach a plateau on the complexation plot. This may be due to a 
lower complexation constant of the host and Na+.   All four compounds form a 1:1 host-
guest complexation based on the data obtained.9  
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 DCM:MeOH [Sensor] Abs. Abs. [base] [ion] [Cat/Host]  Initial  Final Fluorescence 
 
 1:1 x10-5 M λ 333nm λ 365nm x10-5 M x10-5 M  Fl. Area  Fl. Area  Enhancement 
 
 P5 1.15 0.153   0.055 91.5 79 2928 30251 10 
 
 P6 1 0.165   0.0935 10.5 10 8013 45965 6 
 
 A5 1.22   0.048 0.055 100 82 2875 28034 10 
 
 A6 1.1   0.038 0.055 10 9 5 360 68 
 
 A6 DCM 0.55   0.02 0.0875 1.13 2 1035 40629 39 
 
 
 
Table 2: Molar concentrations of host, base, and cation used for fluorescence testing are 
shown, along with the fluorescence enhancement, FE, which was calculated based on the 
increase in fluorescence areas upon cation addition. 
 
 
 
 Table 2 shows the calculated enhancement of the fluorescence area upon the 
addition of the cation indicated.  The plateau cation concentration compared to the host 
concentration is shown along with the total increase in fluorescence upon cation 
complexation.  The amount of fluorescence enhancement upon the addition of the cation 
shows that PET does in fact take place with fairly high sensitivity.   
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Figure 6: Fluorescence emission spectra (λex 333 nm) of P5 (1.15 × 10-5 M) in DCM: 
MeOH (1:1) with added BTMAH (5.5 × 10-7 M) as a function of [Na+], [0 µM −1000 
µM]. 
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Figure 7: Fluorescence area increase of P5 (1.15 × 10-5 M) in DCM: MeOH (1:1) with 
added BTMAH (5.5 × 10-7 M) as a function of [Na+], [0 µM −1000 µM]. 
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Figure 8: Fluorescence emission spectra (λex 333 nm) of P6 (1.00 × 10-5 M) in DCM: 
MeOH (1:1) with added BTMAH (9.35 × 10-7 M) as a function of [K+], [0 µM −205 
µM]. 
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Figure 9: Fluorescence area increase of P6 (1.00 × 10-5 M) in DCM: MeOH (1:1) with 
added BTMAH (9.35 × 10-7 M) as a function of [K+], [0 µM −205 µM]. 
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Figure 10: Fluorescence emission spectra (λex 365 nm) of A5 (1.22 × 10-5 M) in DCM: 
MeOH (1:1) with added BTMAH (5.50 × 10-7 M) as a function of [Na+],  [0 µM −1400 
µM]. 
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Figure 11: Fluorescence area increase of A5 (1.22 × 10-5 M) in DCM: MeOH (1:1) with 
added BTMAH (5.50 × 10-7 M) as a function of [Na+], [0 µM −1400 µM]. 
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Figure 12: Fluorescence emission spectra (λex 365 nm) of A6 (1.10 × 10-5 M) in DCM: 
MeOH (1:1) with added BTMAH (5.50 × 10-7 M) as a function of [K+], [0 µM −175.0 
µM]. 
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Figure 13: Fluorescence area increase of A6 (1.10 × 10-5 M) in DCM: MeOH (1:1) with 
added BTMAH (5.50 × 10-7 M) as a function of [K+], [0 µM −175.0 µM]. 
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Protonation of the nitrogen atom in the azacrown can potentially block the 
electron transfer process and for this reason, the organic base, benzyltrimethylammonium 
hydroxide (BTMAH), was added to minimize protonation.7,9  In fact, the addition of base 
to solutions of A6 in the absence of potassium ions causes a 4-fold decrease in the 
fluorescence intensity, consistent with this protonation effect. However, the addition of 
excess base caused an increase in fluorescence intensity.   
Nevertheless, some fluorescence is still observed. It is difficult to unambiguously 
determine the origin of this fluorescence, i.e. whether it reflects the intrinsic rate constants for 
fluorescence and electron transfer in this molecule or whether there is a low background 
concentration of potassium, sodium or other cations present as impurities. Indeed, the intensity of 
the fluorescence emission in the presence of base and in the absence of added potassium is 
somewhat variable and it is possible to reduce this intensity by using rigorously cleaned 
glassware during sample preparation, suggesting that at least some of the effect is due to 
impurity ions.44,45  
 Upon testing, A6 was found to have a fluorescence enhancement, FE, for K+ 
greater than 50. This finding is consistent with published data where for the same 
compound the F.E. was found to equal 47.3   
 
II. 1,3 alternate calixarene[4]arenecrown-5 (I) 
i. Synthesis 
The synthesis of 1,3 alternate calixarene[4]arenecrown-5 (I) can be found in reference 46.  
A structure of the molecule is given in Figure 14. 
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Figure 14: 1,3 alternate calixarene[4]arenecrown-5 (I) 
 
 
 
ii. Fluorescence Data 
The aza-crowns, P5, P6, A5, A6, were model compounds for more complex 
fluoroionophores designed to exhibit higher cation selectivity. A6 was synthesized as a model for 
I because it contains both the same chromophore/amine electron transfer system and based on 
molecular modeling, the electrostatic characteristics of the complexation sites are qualitatively 
similar in both compounds.  The synthesis of A6 also served as a baseline for determining 
whether selectivity and sensitivity of the azacrown moiety is enhanced by the incorporation of 
the calix[4]arene group.  Thus, the aza-crown moiety was combined with a calixarene group and 
the resulting molecule was tested for cation response and selectivity.   To provide a consistent 
comparison of A6 to I, fluorescence spectra of A6 were obtained in DCM, (shown in Figure 15).  
O
O O
O
OO
N
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The results obtained using A6 in DCM show over a ca. 50–fold enhancement of the fluorescence 
intensity upon addition of potassium ions. [Figure 16] 
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Figure 15: Fluorescence emission spectra (λex 355 nm) of A6 (5.50 × 10-6 M) in DCM 
with added BTMAH (8.75 × 10-7 M) as a function of [K+], [0 µM - 11.3 µM]. 
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Figure 16: Fluorescence area increase of A6 (5.50 × 10-6 M) in DCM with added 
BTMAH (8.75 × 10-7 M) as a function of [K+]. 
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Figure 17 shows the fluorescence spectra obtained for I in the absence and presence of 
added potassium acetate in dichloromethane solution.  In order to compare directly the behavior 
of A6 and I, the spectrum for I in the absence of potassium ions was normalized to that of A6 to 
account for differences in sample absorbance at the excitation wavelength. As with A6, the 
fluorescence intensity of I in the presence of added base, increases dramatically with addition of 
potassium ions, although both the rate of increase as a function of ion concentration and the 
dynamic range for I is considerably less than for A6, (8.5-fold and 50-fold increases 
respectively). 
Figure 17: Fluorescence emission spectra (λex 355 nm) of I (1.1 × 10-6 M) in dichloromethane 
with added BTMAH (1.0 × 10-7 M) as a function of [K+].  a: 0 µM, b: .5 µM, c: 1 µM, d: 1.5 
µM, e: 2 µM, f: 2.5 µM, g: 3 µM. 
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The reason for this reduced response of I compared to A6 is unclear. One potential 
explanation is that the ion occupies a site in I relative to the electron lone pair on the azacrown 
nitrogen atom as well as to the anthryl fluorophore that is different than in A6.  For example, if 
the most stable position of the ion in the complex is at a greater distance from the nitrogen lone 
pair in I, this could lead to a weaker electrostatic interaction and result in less effective 
interference with the electron transfer quenching process. Such an effect could conceivably be 
caused by an interaction between the ion and the π-systems of the phenyl rings of the calixarene 
group.  The binding of cations through π interactions has been observed for other host-guest 
molecules47,48,49 as well as the 1,3 alternate calix[4]arenecrown-5 used in the present study.50 In 
fact, electrostatics calculations on the potassium ion-I complex point out significant changes in 
charge density in the calixarene phenyl rings upon complexation.  Additionally, it was found that 
when the structure of A6 complexed with potassium ion was minimized, a K+…N distance = 3.00 
Å was optimal whereas a K+…N distance of 3.48 Å was observed for I.   Therefore, a weaker 
interaction with the amine electron donor and consequently a reduction in the fluorescence 
response would be expected for I compared to A6. 
 
iii. Solvent Effects 
Previous studies of analogous anthryl-benzocrown ether calixarenes indicated a 
considerable and complex solvent effect on the intensity of fluorescence in such compounds.16 
Specifically, addition of methanol to dichloromethane was observed initially to cause an increase 
in the fluorescence presumably due to complexation of the methanol with the oxygen atoms of 
the benzocrown ether, i.e., electron transfer was less efficient. With continued addition of 
methanol, the increase in polarity in turn increased the efficiency of electron transfer and led to a 
 51 
decrease in the fluorescence.  Given this reported medium effect and its potential importance in 
the operation of a sensor based on this molecular structure, we have investigated the effect of 
solvent on I, both in the absence and presence of added potassium ions.  In the absence of ions, 
the addition of methanol to the dichloromethane solutions caused an increase in the fluorescence 
intensity at small methanol concentrations and then a decrease as the methanol concentration was 
increased further. This behavior is similar to that reported for the benzocrown systems.1   It is 
likely here that at low methanol concentrations, the increase in fluorescence intensity is due to a 
hydrogen bond interaction between methanol and the azacrown nitrogen. The fact that the effect 
of small concentrations of added methanol is more pronounced in I than in the previously studied 
benzocrown compounds is consistent with the fact that the nitrogen lone pair is a more localized 
source of electrons for the fluorescence quenching process than the 1,2-dimethoxybenzo moiety 
within benzocrown ethers.  However, at higher methanol concentrations the drop in fluorescence 
intensity observed can be ascribed to an increase in the efficiency of electron transfer due to an 
increase in solvent polarity.  This polarity effect overshadows the hydrogen bonding effect. 
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Figure 18: Delta fluorescence response to K+ of I as a function of the mole fraction of 
dichloromethane in methanol. 
 
In the presence of added potassium ions, an additional effect of solvent is observed.  
Figure 18 shows the delta response of I as a function of the mole fraction of dichloromethane in 
methanol. The delta response is determined from the slope of the fluorescence intensity versus 
ion concentration curve at a specific solvent composition.  It is clear that as the mole fraction of 
methanol decreases, the delta response increases dramatically.  We ascribe this behavior to a 
solvation effect in that, as the solvent polarity decreases with increased dichloromethane 
concentration, the potassium ions seek out a more energetically favorable solvation environment, 
namely the complexation site in I.  This response to solvation is expected to have an important 
impact on the composition of the membrane that is eventually chosen to host I in sensor 
applications.   
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The anthryl azacrowncalix[4]arene, I, complexes with potassium ions in organic 
solution triggering a substantial increase in anthryl fluorescence emission through the 
disruption of the PET quenching process. Preliminary measurements indicate that the 
selectivity for potassium ions over other alkali metal cations particularly sodium and 
lithium for I is increased dramatically over that of the anthryl azacrown model 
compound, A6.  These preliminary solution phase studies indicate a 1:1 complexation 
between I and the ion, suggesting that I could be sensitive to potassium in the normal 
physiological concentration range once incorporated into a sensor. Furthermore, the 
observed fluorescence response to changes in solvent polarity suggests that the sensor 
substrate composition will have an important impact on the efficiency of I as an 
ionophore and could allow further optimization of sensitivity and selectivity. 
 
III. Bicyclic Peptide V 
 
i. Design of Synthetic Route 
 
 Bicyclic peptide V was designed based on molecular modeling using MOE.  The 
modeling indicates that the use of V as a fluorionophore for ammonium cations should be 
more selective than that of the currently used standard, nonactin.   
In order to construct bicyclic peptide V, several different possible synthetic routes 
that were examined.  Ultimately, the core part of the molecule that needs to be 
constructed is the linear peptide with both side chains deprotected, shown in Figure 19. 
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Figure 19: Open chain unprotected linear peptide. 
 
Initially, we intended to synthesize the linear peptide with a end terminal Fmoc 
protecting group using a Wang Resin.  However, it was determined that the Fmoc would 
be removed by the reagents used. Specifically, the use of base in subsequent steps would 
cleave the Fmoc group prior to the desired step. The option of using a terminal tBoc 
protecting group was then explored because it is stable under basic conditions.  However, 
the use of tBoc precludes the use of a Wang Resin.  Since 95% TFA is required to cleave 
the peptide from this resin, the tBoc group would be completely removed. 
 Questions arose as to whether cyclization of the main outer peptide ring would be 
a viable option.  But, the deprotection of the alcohols could cause an unknown amount of 
cyclization between the side chains and the free amine or carboxylic acid.  It was decided 
that the better option would be to attempt to cyclize the side chains first while leaving the 
amine protected by the tBoc group. 
 This decision then meant that a different resin would have to be employed, in 
which the cleavage conditions would not remove the tBoc protecting group.  Various 
resins were explored, such as those that undergo photo cleavage and one that may be 
cleaved in NaOH.  It was decided that the best alternative may be to use the 2-chloro-
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trityl chloride resin, which cleaves in 5% TFA.  Under this condition, the tBoc group 
should not be removed.   
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Scheme 14: Retrosynthetic analysis of bicyclic peptide (V) 
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ii. Preliminary Synthesis 
 
Decisions toward a synthetic route of constructing bicyclic peptide V were based 
on trial syntheses.  The synthetic route was designed around the need for having a stable 
amine protecting group, while being able to activate the alcohols to facilitate the 
pyrenemethyl amine addition across the homo-serine side chains, as in Scheme 14, 
Structure 3.  Initial attempts were directed toward activating the alcohol while still using 
a Fmoc protecting group on the residue. This would mean that either the Wang or the 
HMBA resins, which have been frequently used within our group and known to give 
good yields, could be employed and cleaved in strong acid without affecting the 
protecting group. A synthetic procedure that enabled the activation of the alcohol while 
not removing the end protecting group on the amine of the linear peptide was needed in 
order to prevent unwanted side reactions.  In an attempt to find a method of activating the 
alcohols without removing the Fmoc, several trial syntheses were attempted.  Syntheses 
tried and results obtained are described below. 
 
Based on a procedure found in Organikum46 Fmoc- Ser-OH (1.0 eq., 3.1mmol) 
was mixed with tosyl chloride (1.1 eq., 3.7 mmol) and DIPEA (1.6 eq., 4.9mmol) in 
DCM.  After 4 ½ hours at room temperature, 3 g of ice were added along with HCl (2-3 
mL). The organic layer was then washed with water and dried with Na2SO4, but yielded 
little evidence that the tosylation had taken place.  The reaction was then re-run using 5 
eq of DIPEA; however it was determined that these basic conditions removed the Fmoc 
group. 
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Figure 20: Cyclizations of Fmoc-L-Ser-OH under basic conditions to form either a six 
membered ring though stability or a cyclized five membered ring.   
 
  It is possible that once the base removes the proton on the carboxylic acid, the 
Fmoc-Ser-OH is stabilized by the formation of a six membered ring between the alcohol 
and the carboxylic acid, causing the alcohol of the serine to be much less reactive. The 
other possibility is that under basic conditions, the alcohol is able to attack the carbonyl 
and cyclizes to form a five membered ring, shown in Figure 20.  To avoid these possible 
cyclizations, the methyl ester was formed and used in further reactions.  
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Figure 21: Structures of triflic chloride, triflic anhydride, and tosyl chloride. 
 
Because a triflic group is a better leaving group than a tosyl group51, subsequent 
reactions were attempted to find an efficient method for triflating the alcohol.  [Figure 
21] Fmoc-Ser-O-Me (1 eq., 7.4mmol) and DIPEA (2eq, 14.8mmol) were stirred at –78C 
in DCM and triflic anhydride (1.1 eq., 8.1mmol) added dropwise over 1 hr.  The organic 
layer was rinsed with water and then NaHCO3.  It was determined that he Fmoc was also 
removed during this reaction.  The above reaction was repeated using Fmoc- Ser-O-Me 
(1.0 eq., 5.8mmol) and tosyl chloride (1.1 eq., 6.4 mmol) in DCM at room temperature 
and then cooled to 0C. DIPEA (1.1 eq., 6.4mmol) was added dropwise over a ½ hour.  
After 2 ½ hours at room temperature, 50 g of ice were added along with HCl (20 mL). 
The organic layer was then washed with water and dried with Na2SO4. The Fmoc was 
once again removed under these basic conditions. 
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Figure 22: Structure of Bzl-L-Ser-OMe 
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The use of an N-protecting benzyl group was then employed.  Bzl- Ser-O-Me (1.0 
eq., 5.0mmol), Figure 22, was mixed with tosyl chloride (1.1 eq., 5.5mmol) and Et3N (2 
eq., 10mmol) in chloroform.  After 4 ½ hours at room temperature 3 g of ice were added 
along with HCl (2-3 mL). The organic layer was then washed with water and dried with 
Na2SO4.  The products were not kept under inert conditions and based on TLC’S (3:1 
DCM:Hexane), decomposition took placed, therefore the reaction was repeated under 
inert conditions.  Bzl- Ser-O-Me (1.0 eq., 36.7mmol) was mixed with tosyl chloride (1.1 
eq., 40.4mmol) and Et3N (2 eq., 73.4mmol) in chloroform.  After 4 ½ hours at room 
temperature, 3 g of ice were added along with HCl (2-3 mL). The organic layer was then 
washed with water and dried with Na2SO4.  TLC plates were run in DCM:Hexane (4:1).  
Based on NMR, cyclization took place. Spectra obtained were identical to previous NMR 
spectra obtained when attempting to add an alkyl chain to the alcohol of Bzl- Ser-O-Me.   
The next attempt made was to brominate the alcohol of Fmoc-Ser-OH.  Fmoc-
Ser-OH (3.1mmol, 1.0g) and PBr3 (34mmol, 0.32mL) were refluxed over night in DCM.  
Organic layer was washed with water and 3N NaOH (5mL) to convert from an acid 
bromide to a carboxylic acid. TLC plates were run in DCM:EtOAc (19:1).   
The decision was made to utilize an end tBoc protecting group, which is stable to 
basic conditions that are needed to activate the alcohol.  This decision also meant that a 
very acid sensitive resin would need to be employed.  Because the tBoc group is cleaved 
in 50% TFA, either a photolytically-cleaved resin, base-cleaved resin, or very acid-
sensitive resin was required.  Light sensitive resins are extremely expensive, and one 
resin that could be cleaved in base was found, but there is evidence that cleavage is 
inefficient based on a private communication with Advanced Chemtech.  The decision 
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was made to attempt the synthesis of the linear peptide on the 2-chlorotrityl-chloride 
resin which cleaves in 5% TFA a condition that presumably would not remove the tBoc. 
 
iii. Synthesis 
 The linear peptide was loaded with Fmoc-Ala-OH using DIPEA and tested for its 
loading amount.  By using a known amount of Resin-Ala-Fmoc(0.010g), the resin can be 
subjected to Fmoc deprotection conditions of (20% piperidine).  The absorption spectra 
of the Fmoc in solution can then be measured and the concentration of Fmoc in solution 
calculated.  The moles of Fmoc present indicate amount of loading on the resin.  Both 
times that the resin loading was tested it was found to be above 95%.   
 The linear peptide was synthesized using solid phase Fmoc strategy. Some 
adaptations were made to the usual synthesis to facilitate better coupling yields.  It was 
experimentally determined that a higher coupling yield was obtained when a slightly 
higher amount of PyBOP was used. This observation may be due to two possibilities; 
either the higher amount of PyBOP present increased the amount of activated esters 
formed thereby increasing the likelihood for amino acid coupling, or the PyBOP that was 
being used had previously been exposed to air/water and some of the chloride had been 
removed. The only other alteration that was made to the previously used strategy was the 
use of DCM along with DMF.  Due to a shortage of DMF, the use of DCM was 
employed for coupling, and found to dramatically increase the amount of coupling, 
especially for the bulkier groups.  When only DMF is used for the addition of the homo-
serine, the reaction mixture becomes thick and frothy.  The use of DCM drastically 
increases the solubility of the mixture.   
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 Coupling of each amino acid using a Fmoc strategy proceeds via the mechanism 
shown below in Scheme 15.  Removal of the hydrogen from the acid to form the anion, 
leads to attack on PyBOP.  An HOBT anion is then removed from the PyBOP to yield the 
activated ester of the amino acid.  Nucleophilic attack of HOBT on the carbonyl causes 
the removal of the PyBOP ester, and enables the amine of the previous amino acid to 
attack the carbonyl and remove the HOBT, causing coupling to take place.   
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Scheme 15: Solid phase peptide coupling using PyBOP, HOBT, and DIPEA. 
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 The Kaiser test, which indicates the presence of free amine, was used to insure 
proper coupling had taken place during each step.  Some coupling steps were repeated 
twice to insure complete coupling because slightly negative Kaiser tests were obtained 
after single coupling. As the peptide became longer, and especially after the addition of 
each homo-serine, slightly negative Kaiser tests were obtained (light purple beads, rather 
than yellow).  Based on later mass spectra, this is not due to any significant amount of 
incomplete coupling of any of the residues.  According to Nova BioChem, larger, bulky 
groups are known to aggregate, thereby giving a slightly negative Kaiser test.52   
 In a previous synthesis, the cleavage reagents used were AcOH: TFE: DCM 
(2:2:6) for 2 hours, which did not completely, if at all, cleave the peptide.  Therefore, 
cleavage of the peptide was done following another Nova BioChem procedure to prevent 
the removal of the trityl groups.  1% TFA in DCM (42mLs) was bubbled through the 
peptide synthesizer for 5 minutes and then filtered into 10% pyridine in methanol to 
quench the reaction.  [Scheme 16]  Each fraction was collected and visualized using TLC 
(EtoAc:MeOH, 3:1).  The first 2 fractions contained the majority of peptide present 
(2.020g); subsequent fractions contained a smaller amount of peptide (0.400g).  A lower 
overall peptide yield was obtained than expected.  This may be due to the fact that either 
incomplete loading took place initially, which is doubtful due to the high calculated 
loading yield from the Fmoc UV testing, or the peptide may be partially cleaved during 
coupling reactions or rinses.  Because the trityl cation on the resin is extremely stable, i.e. 
the product of cleavage, it is possible that some unwanted cleavage took place. 
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 Scheme 16: 2-Chlorotrityl Chloride resin cleavage using 1% TFA in DCM 
 
 The peptide was then precipitated from each cleavage mixture by rotoevaporation 
to 5% volume and then adding de-ionized water.  A white gummy precipitate was 
immediately formed on the glass.  The pH of the water was then tested to insure that 
acidic conditions were not present since they could lead to cleavage of the tBoc group.  
The major amount of precipitate from the first two cleavage batches was found to have a 
pH of about 6-7.  a small amount of pyridine was added to insure acidic conditions were 
not  present (to a pH of ~7).  The minor fraction was found to have a pH of ~0-1, and 
therefore a significant amount of base was quickly added.  This fraction of peptide was 
kept separate from the major fraction.  Both fractions were cooled in the fridge overnight.   
 The deprotection of the trityl groups was done using 1% TFA in DCM 2.5 eq. 
Triisopropylsilane (TIS).  TIS is used as a carbocation scavenger by acting as a hydride 
donor.53 Cleavage of the trityl groups yields unprotected alcohols on the homo-serine 
residues along with tritylmethane, shown in Scheme 17. 
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Scheme 17: Deprotection of alcohol using 1% TFA and 2.5 eq. TIS. 
 
 In order to form a tertiary amine connecting both homo-serine residues, reactivity 
of the alcohols would need to be increased.  Several options were explored before the 
linear peptide was synthesized to provide a suitable leaving group for the amine addition 
via a SN2 mechanism.  The utilization of the triflate leaving group was determined to be 
the most viable option to attain a reasonable product yield.  
Once the linear peptide with the end tBoc group were synthesized, the addition of 
the amine was attempted. [Scheme 18]  2.2 eq. of triflic chloride was added to dropwise 
to the linear peptide and 3.0 eq. of  Et3N with cooling.  After 1 hour at room temperature, 
the yellow solution was evaporated to yield a yellow oil.  The oil was re-dissolved in 
acetonitrile to a volume of 350 mL and 1.0 eq. of 1-pyrenemethylamine were added along 
with 4.0 eq. of base.  A low concentration was used (0.95mg/mL) to ensure that the 
reaction would be intermolecular rather than intramolecular.  The reaction was carried 
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out overnight and the reaction mixture changed from cloudy orange to clear.   
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Scheme 18: Triflation and pyrene addition mechanism 
 
Based on TLC, 3 spots were obtained in DCM:MeOH (10:1); one faint spot that 
barely moved, one at an Rf of  0.45, and one at an R f of 1.0.  All spots appeared under 
the UV lamp, and indicated the presence of the pyrene group.  The middle spot 
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corresponded to the pyrene-containing starting material and the bottom spot might 
possibly be the linear peptide with one pyrene attached.  Possibly, the top spot was the 
desired product.  The crude NMR is shown in the appendix and integrates fairly well for 
the desired product.   
A column was then run using the same solvent system and many more than three 
fractions were obtained, none of which (based on mass spec and NMR) contained the 
desired product.  It is assumed that decomposition through photo-induced oxidation took 
place on the silica and decomposed the products.  Since the structure has a very similar 
make-up to the aza-crown ether chromophore compounds, these compounds also 
underwent photo-oxidation.  
 The linear peptide was successfully synthesized and the alcohols deprotected.  
The addition of the amine will be repeated using a similar procedure as above.54  The 
products formed will then be recrystalized and not subjected to silica. If that product is 
obtained, the amino tBoc will then be removed using 50% TFA in DCM and cyclization 
of the peptide ring done.   Fluorescence testing will then be performed on the bicyclic 
peptide to determine its selectivity and sensitivity toward complexing ammonium cations.   
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Conclusions 
 
Based on studies of P6, P5, A6, and A5, it can be concluded that photo-electron transfer 
from the amine group quenches the fluorescence of the chromophore in the absence of 
cations.  Therefore, by monitoring fluorescence emission intensity it is possible to 
determine the concentration of cations in solution.  1,3 alternate 
calixarene[4]arenecrown-5 was synthesized and found to form a 1:1 complex and have 
selectivity for potassium over all other alkali metal cations including sodium and lithium. 
Our current molecule, V, is expected to behave similarly based on its molecular 
architecture, and is predicted to selectively bind ammonium cations over potassium 
cations.  Future work will focus on completing the synthesis of molecule V and 
characterizing its photophysical properties in the presence of ammonium cations.   
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